Shopping Cart 0
Cart Subtotal
USD 0

University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Maryland (UMD) is a research university that operates colleges and schools. The university offers academic departments and programs including agricultural and resource economics, American studies, animal and avian sciences, anthropology, applied mathematics and scientific computation program, Arabic studies, behavioral and community health, biochemistry, bioengineering, and chemical physics program, among others. It provides services to college of agriculture and natural resources, school of architecture, planning, and preservation, college of arts and humanities, college of behavioral and social sciences, robert h. smith school of business, college of computer, and college of education, among others. The university also offers graduation, post graduation, and phd courses. UMD is headquartered in College Park, Maryland, the US.

University of Maryland-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9

University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Maryland, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12

Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 13

Institute for Bioscience and Biotechnology Research Enters into Partnership with Frederick National Lab 14

GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 15

Genisphere Enters into Research Agreement with University of Maryland 16

ConverGene Enters into Research Agreement with University of Maryland School of Medicine 17

ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 18

Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 19

University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 20

Licensing Agreements 21

Cellth Systems Enters into Licensing Agreement with University of Maryland 21

Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 22

Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 23

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 24

Educational and Scientific Enters into Licensing Agreement with University of Maryland 25

SilcsBio Enters Into Licensing Agreement With UM Ventures 26

University of Maryland-Key Competitors 27

University of Maryland-Key Employees 28

University of Maryland-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 31

Government and Public Interest 31

Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 31

Aug 30, 2018: Avera Research receives USD 17.1 million National Institutes of Health grant 32

Aug 21, 2018: Mason researcher part of team awarded USD 2.5 million grant for investigating remedies to deadly virus 33

Feb 08, 2018: UMD Researchers Develop Breakthrough Technique to Combat Cancer Drug Resistance 34

Oct 27, 2017: New molecule shows promise in HIV vaccine design 35

Mar 29, 2017: NIH R01 Award to Develop Next Generation Non-nucleoside RT HIV Inhibitors 36

Product News 37

Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 37

08/03/2017: UM SOM Received USD 2.47 Million Grant To Develop Traveler's Diarrhea Vaccine 39

Jun 13, 2017: UMD bioengineers develop new technologies to drive next-generation therapies for MS 40

Other Significant Developments 41

Jul 31, 2018: New cell lines produce nist monoclonal antibody for improved manufacturing of biologic drugs 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List Of Figure

List of Figures

University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Maryland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Maryland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

University of Maryland, Pharmaceuticals & Healthcare, Key Facts 2

University of Maryland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Maryland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Maryland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Maryland, Deals By Therapy Area, 2012 to YTD 2018 8

University of Maryland, Medical Devices Deals, 2012 to YTD 2018 9

University of Maryland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

University of Maryland Enters Into Licensing Agreement With Harpoon Medical 12

Innovate Biopharma Enters into R&D Agreement with University of Maryland School of Medicine 13

Institute for Bioscience and Biotechnology Research Enters into Partnership with Frederick National Lab 14

GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 15

Genisphere Enters into Research Agreement with University of Maryland 16

ConverGene Enters into Research Agreement with University of Maryland School of Medicine 17

ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 18

Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland 19

University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx 20

Cellth Systems Enters into Licensing Agreement with University of Maryland 21

Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 22

Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems 23

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 24

Educational and Scientific Enters into Licensing Agreement with University of Maryland 25

SilcsBio Enters Into Licensing Agreement With UM Ventures 26

University of Maryland, Key Competitors 27

University of Maryland, Key Employees 28

University of Maryland, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Maryland, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.